Advantage Living Center - Armada | |
22600 Armada Ridge Rd, Armada, Michigan 48005 | |
(586) 784-5322 | |
Name | Advantage Living Center - Armada |
---|---|
Location | 22600 Armada Ridge Rd, Armada, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 67 |
Occupancy Rate | 84.63% |
Medicare ID (CCN) | 235609 |
Legal Business Name | Rhema - Armada Operating Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1134222318 |
Organization Name | FAIR ACRES NURSING HOME, INC. |
Doing Business As | THE VILLAGE REHABILITATION AND CARE CENTER |
Address | 22600 W Main St, Armada, MI 48005 |
Phone Number | 586-784-5322 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
NPI Number | 1467124073 |
Organization Name | ARMADA VILLAGE MI WELLNESS LLC |
Address | 22600 W Main St, Armada, MI 48005 |
Phone Number | 718-838-1501 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
NPI Number | 1568134179 |
Organization Name | ARMADA MI OPCO LLC |
Address | 22600 W Main St, Armada, MI 48005 |
Phone Number | 718-838-1501 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
NPI Number | 1912360595 |
Organization Name | RHEMA ARMADA OPERATING LLC |
Address | 22600 W Main St, Armada, MI 48005 |
Phone Number | 586-784-5322 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.1 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.67 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 76.09 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.29 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.59 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.09 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.31 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 7.28 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 21.11 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.25 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 8.16 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 50.42 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.76 | 82.93 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.
Today marks World Food Day, with the aim of bringing "awareness to the issue of hunger," as the world faces "more mouths to feed but fewer farmers to grow the needed crops," Deutsche Welle reports.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports.
A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
› Verified 5 days ago
Advantage Living Center - Armada Location: 22600 Armada Ridge Rd, Armada, Michigan 48005 Phone: (586) 784-5322 |